Ati cautat: terapie pacienti
Protocol terapeutic: N030C – DUREREA CRONICĂ DIN CANCER (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N022G – DCI GALANTAMINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N021G – DCI RIVASTIGMINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N020G – DCI DONEPEZILUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N012F – DCI LAMOTRIGINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N001F – DCI MEMANTINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: M003M – OSTEOPOROZA – ACIDUM ALENDRONICUM**; ACIDUM RISEDRONICUM**; ACIDUM ZOLENDRONICUM**; COMBINAŢII (ACIDUM ALENDRONICUM + COLECALCIFEROLUM)**; DENOSUMABUM(Prolia)**; TERIPARATIDUM**(original si biosimilar) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: LB01B – HEPATITA CRONICĂ VIRALĂ ŞI CIROZĂ HEPATICĂ CU VHB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L050C – DCI INTERFERONUM ALFA 2A (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L048C – DCI FLUDARABINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
